Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

MRS1220 is an adenosine A3 receptor antagonist (Ki = 0.65 nM for the human receptor).1 It is selective for human adenosine A3 receptors over rat adenosine A1 and A2receptors (Kis = 305 and 52 nM, respectively). MRS1220 inhibits [35S]GTPγS binding in HEK293 cells expressing human adenosine A3 receptors (IC50 = 7.2 nM). In vivo, MRS1220 (0.15 mg/kg) decreases tumor growth and angiogenesis in a rat C6 glioma model.2
WARNING This product is not for human or veterinary use.
1. Pharmacological characterization of novel A3 adenosine receptor-
2. The adenosine A3 receptor regulates differentiation of glioblastoma stem-